Trial Profile
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Epirubicin
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Feb 2016 New trial record